Literature DB >> 12392158

Immunoglobulin superfamily expression in primary retinoblastoma and retinoblastoma cell lines.

Michele C Madigan1, Philip L Penfold, Nicholas J C King, Francis A Billson, Robert M Conway.   

Abstract

Retinoblastoma (Rb) is the most common intraocular tumor of childhood. In this study we examined primary Rb specimens and Rb cell lines for the expression of immunoglobulin superfamily (IgSF) antigens: MHC class I and II (MHC-I and MHC-II), neural cell adhesion molecule (NCAM), intercellular adhesion molecule-1 (ICAM-1), and Thy-1, which play an important role in immune system and tumor cell interactions. MHC-I and-II, ICAM-1 (CD54), NCAM (CD56), and Thy-1 (CDw90) immunoreactivity was studied in eight primary Rb biopsy specimens using immunohistochemistry, three using immunoelectron microscopy, and six Rb cell lines using flow cytometry (FCM). Parenchymal and vascular-associated cells, phenotypically similar to retinal microglia, strongly expressed MHC-II immunoreactivity and were distributed throughout primary Rb specimens. However, MHC-II expression on Rb cell lines was similar to nonspecific control levels. Tumor cells in primary Rb specimens displayed high NCAM, moderate Thy-1, and low MHC-I and ICAM-1 immunolabeling. Tumor vasculature expressed low to moderate MHC-I and ICAM-1 immunoreactivity and moderate Thy-1 immunoreactivity. NCAM was not detected on the vasculature of primary Rb specimens. Rb cell lines displayed variable expression of Thy-1, ICAM-1, and MHC-I. NCAM was highly expressed on five of six Rb cell lines. The high levels of constitutive NCAM immunoreactivity on Rb tumor cells confirm the neuroectodermal origins of this tumor. Additionally, the variable expression of Thy-1 may suggest separate neural lineages or differences in the maturational status ofsome Rb tumors. The presence of a population of infiltrating MHC-II-positive cells in primary Rb tumors has implications for immunomodulation of Rb growth.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12392158

Source DB:  PubMed          Journal:  Oncol Res        ISSN: 0965-0407            Impact factor:   5.574


  2 in total

1.  Dinutuximab Synergistically Enhances the Cytotoxicity of Natural Killer Cells to Retinoblastoma Through the Perforin-Granzyme B Pathway.

Authors:  Huixue Wang; Jie Yang; Hui Pan; Mei Chee Tai; Mohamed H Maher; Renbing Jia; Shengfang Ge; Linna Lu
Journal:  Onco Targets Ther       Date:  2020-05-08       Impact factor: 4.147

2.  PPAR-gamma, Microglial Cells, and Ocular Inflammation: New Venues for Potential Therapeutic Approaches.

Authors:  Fiorella Malchiodi-Albedi; Andrea Matteucci; Antonietta Bernardo; Luisa Minghetti
Journal:  PPAR Res       Date:  2008       Impact factor: 4.964

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.